(NASDAQ:CHA), SHANGHAI, Aug. 29, 2025 (GLOBE NEWSWIRE) — Chagee Holdings Limited (NASDAQ: CHA) (“Chagee” or the “Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Operational Highlights1 As of June 30, 2025, there […]
(TSX-V:HOH), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, Aug. 29, 2025 (GLOBE NEWSWIRE) — High Arctic Overseas Holdings Corp. (TSXV: HOH) (the “Corporation” or “High Arctic Overseas”) is pleased to announce
(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Aug. 29, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century,
(NASDAQ:ELDN), IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on Friday, September 5, 2025, at 9:10 a.m. ET (6:10 a.m. PT). To register in advance for
(TSX:FFH),(TSX:FFH.U), TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax“) (TSX: FFH and FFH.U) today announced its intention to redeem (i) all of its 7,719,843 outstanding Cumulative 5-Year Rate Reset Preferred Shares, Series G (the “Series G Shares“), and (ii) all of its 2,280,157 outstanding Cumulative Floating Rate Preferred Shares, Series H
(NASDAQ:ALMS), SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences: Cantor Global Healthcare Conference 2025 in New York, NY on September 3 at 9:45 am
(NASDAQ:ARVN), NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in fireside chats at two upcoming investor conferences: Wells Fargo Healthcare Conference on Thursday, September 4. A live audio webcast
(NASDAQ:GLPI), WYOMISSING, Pa., Aug. 29, 2025 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (the “Company”), announced today that the Company's Board of Directors has declared the third quarter 2025 cash dividend of $0.78 per share of its common stock. The dividend is payable on September 26, 2025 to shareholders of record on
(NasdaqGM:FOLD), PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September. Cantor Global Healthcare Conference 2025 in New York, NY, on Wednesday, September 3, 2025, at 10:20 a.m. ET Morgan Stanley 23rd Annual Global Healthcare Conference 2025
(TSX-V:CNVI),(OTC US:CNVIF),(OtherOTC:CNVIF), US FDA 510(k) submission remains on track for calendar Q3 2025 Successful validation testing of Novasight Hybrid(TM) system with key opinion leaders Recent academic publications underscore importance of intravascular imaging and potential of hybrid IVUS / OCT $20 million financing completed in April strengthens balance sheet and supports anticipated U.S. launch TORONTO, Aug.